Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558648 · ClinicalTrials.gov registry record
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 257
- Enrollment target
NCT01558648: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01558648 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 257 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01558648 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate how surgery for esophageal cancer affects the patient's quality of life over time. The investigators hope this study will provide important information that can be used to improve the quality of life of patients with esophageal cancer. This study will also look at how standard tests and information collected from the patients difficulty swallowing can predict the extent of their esophageal cancer before surgery.
Primary Outcome
Pain intensity (average of the four pain severity items) measured by BPI at Post-op Days 1 and 3, after epidural removal, at first post-operative clinic visit, at 4 months
Interventions
- BEHAVIORAL Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2012-03-14 |
| Est. Completion | 2021-08-04 |
What the finished NCT01558648 record still lists
NCT01558648 is an observational study that tracks outcomes without assigning an intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log is the first listed.
NCT01558648 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01558648 about?
NCT01558648 is a clinical study titled "Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer". The goal of this study is to evaluate how surgery for esophageal cancer affects the patient's quality of life over time. The investigators hope this study will provide important information that can be used to improve the quality of life of patients with esophageal cancer. This study will also look ...
What is the current status of trial NCT01558648?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2012-03-14. Estimated completion is 2021-08-04.
What interventions are being tested in trial NCT01558648?
The interventions under investigation include: Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log (BEHAVIORAL).
Who is sponsoring clinical trial NCT01558648?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI